BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6161571)

  • 1. Immunotherapy in children: past, present, and future. (Part I).
    Johnstone DE
    Ann Allergy; 1981 Jan; 46(1):1-7. PubMed ID: 6161571
    [No Abstract]   [Full Text] [Related]  

  • 2. The treatment of seasonal hay fever and asthma in children. A controlled trial of pre-seasonal depot pollen therapy.
    Sanders S
    Practitioner; 1966 Jun; 196(176):811-5. PubMed ID: 5936067
    [No Abstract]   [Full Text] [Related]  

  • 3. The efficacy of E.P.D., a new immunotherapy, in the treatment of allergic diseases in children.
    Caramia G; Franceschini F; Cimarelli ZA; Ciucchi MS; Gagliardini R; Ruffini E
    Allerg Immunol (Paris); 1996 Nov; 28(9):308-10. PubMed ID: 8986246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
    Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
    Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
    Roberts G; Hurley C; Turcanu V; Lack G
    J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of sublingual immunotherapy with a monomeric allergoid in very young children.
    Agostinis F; Tellarini L; Canonica GW; Falagiani P; Passalacqua G
    Allergy; 2005 Jan; 60(1):133. PubMed ID: 15575951
    [No Abstract]   [Full Text] [Related]  

  • 8. New visions in specific immunotherapy in children: an iPAC summary and future trends.
    Halken S; Lau S; Valovirta E
    Pediatr Allergy Immunol; 2008 Aug; 19 Suppl 19():60-70. PubMed ID: 18665964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value and possibilities of immunotherapy in the treatment of allergic rhinitis].
    Pfaar O; Hörmann K; Klimek L
    MMW Fortschr Med; 2006 Feb; 148(5):28-32. PubMed ID: 16518935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS
    J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vaccination with allergens in children].
    Demoly P; Dhivert-Donnadieu H; Bousquet J
    Allerg Immunol (Paris); 2000 Dec; 32(10):397-401. PubMed ID: 11209473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of immunotherapy in 244 children with asthma or allergic rhinitis (author's transl)].
    Wönne R; Hofmann D; Kögel F
    Monatsschr Kinderheilkd (1902); 1978 Mar; 126(3):119-22. PubMed ID: 642944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Safety analysis of Allergovit immunotherapy in patients of allergic rhinitis].
    Chen J; Xiang J; Kong W; Shu H; Shi Q; Tan H
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Mar; 20(5):208-9. PubMed ID: 16722392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublingual immunotherapy for children: Are we there yet? Defining its role in clinical practice.
    Campbell DE
    Paediatr Respir Rev; 2009 Jun; 10(2):69-74; quiz 74. PubMed ID: 19410205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ragweed immunotherapy in adult asthma.
    Klein JS
    N Engl J Med; 1996 Jul; 335(3):204; author reply 205-6. PubMed ID: 8657224
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunotherapy: first do no harm.
    Moss MH
    Immunol Allergy Clin North Am; 2005 May; 25(2):421-39, viii. PubMed ID: 15878464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and specific desensitizing treatment of allergic asthma].
    Bonifazi F; Sanguinetti CM; Vennarucci LS
    Minerva Med; 1980 Jan; 71(3):171-6. PubMed ID: 7354934
    [No Abstract]   [Full Text] [Related]  

  • 18. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis.
    Novembre E; Galli E; Landi F; Caffarelli C; Pifferi M; De Marco E; Burastero SE; Calori G; Benetti L; Bonazza P; Puccinelli P; Parmiani S; Bernardini R; Vierucci A
    J Allergy Clin Immunol; 2004 Oct; 114(4):851-7. PubMed ID: 15480326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyposensitization treatment of allergic diseases].
    Wüthrich B
    Schweiz Rundsch Med Prax; 1993 May; 82(18):529-33. PubMed ID: 8497762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.